John B. Amos Cancer Center at Piedmont Columbus Regional ’s midtown medical complex is the first in Georgia to offer this ...

The "Lyme Disease Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.The report is built to visualize ...

Roche's anti-TIGIT antibody tiragolumab has failed a second phase 3 trial, dousing expectations for the programme and its hopes of finding a companion to its cancer immunotherapy blockbuster ...

The company's XmAb technology platform is a key differentiator, enabling the development of novel antibody and cytokine therapeutics. This proprietary technology underpins Xencor's pipeline and has ...

Novartis has finally given up on iscalimab after deciding that the anti-CD40 antibody is not worth pursuing ... Novartis removed one other drug from its pipeline this morning in the form of ...

A thyroglobulin antibody (TgAb) test looks for certain antibodies that attack the thyroid. The presence of TbAb in high levels may indicate that someone has an autoimmune condition. To conduct a ...

Click here to read more @ c-MET-NSCLC Pipeline Outlook JNJ-6372 is an EGFR-MET bispecific antibody with immune cell-directing activity that targets activating and resistant EGFR and MET mutations ...

Genmab has established itself as a leader in the development of antibody therapeutics ... Key developments in Genmab's pipeline include: 1. Epkinly: This recently launched product has shown promising ...

“The dog’s vaccinated,” you think. “I’m safe.” Right? Well, the reality isn’t so black and white. If a vaccinated dog bites you, the risk of contracting rabies is significantly reduced—but not ...

Genmab A/S (NASDAQ:GMAB), a Danish biotechnology company specializing in antibody therapeutics for ... of approved medicines and a promising pipeline, the company faces both significant ...